AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
manilastandard10h
DTI chief optimistic on PH-US free trade under Trump
Department of Trade and Investments (DTI) Secretary Ma. Cristina Roque expressed optimism about the potential for a renewed ...
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
Avon Freight Group selects INBS’ fingerprint drug testing for three UK sites, reinforcing workplace safety and efficiencyINBS surpasses 400+ ...
Interaksyon on MSN4h
Resto groups to meet over viral ‘fake PWD IDs’ post
The Restaurant Owners Association of the Philippines will meet with Lowbrow Casual Restaurants following the latter's controversial social media post ...